A comparison of replicative senescence and doxorubicin-induced premature senescence of vascular smooth muscle cells isolated from human aorta
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Senescence of vascular smooth muscle cells (VSMCs) contributes to aging as well as age-related diseases of the cardiovascular system. Senescent VSMCs have been shown to be present in atherosclerotic plaques. Both replicative (RS) and stress-induced premature senescence (SIPS) accompany cardiovascular diseases. We aimed to establish the signature of RS and SIPS of VSMCs, induced by a common anticancer drug, doxorubicin, and to discover the so far undisclosed features of senescent cells that are potentially harmful to the organism. Most of the senescence hallmarks were common for both RS and SIPS; however, some differences were observed. 32 % of doxorubicin-treated cells were arrested in the G2/M phase of the cell cycle, while 73 % of replicatively senescing cells were arrested in the G1 phase. Moreover, on the basis of alkaline phosphatase activity measurements, we show that a 7-day treatment with doxorubicin (dox), does not cause precocious cell calcification, which is a characteristic feature of RS. We did not observe calcification even though after 7 days of dox-treatment many other markers characteristic for senescent cells were present. It can suggest that dox-induced SIPS does not accelerate the mineralization of vessels. We consider that detailed characterization of the two types of cellular senescence can be useful in in vitro studies of potential anti-aging factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







![Fig. 8 Telomere length during RS and dox-induced SIPS. a TRF length (kb) expressed as a mean telomere area per cell. b Means of telomere area (pixel per spot) for RS (left) and dox-induced SIPS (right) measured by Q-FISH with Human Chromosome Pan-Telomeric Probes, (ANOVA and Tukey’s a posteriori test). c Representative pictures from Southern blot analysis. Mean TRF length (kb) is shown in brackets (in the legend of the particular lanes). RS (left); Lanes 1 DIG-Molecular Weight Marker, [0.8–21.2], 2 control DNA [7.6 ± 0.2], 3 p5 [9.97 ± 0.06], 4 p10 [7.55 ± 0.60], 5 p15 [6.33 ± 0.19]. dox-induced SIPS (right); Lanes 1 p6 1 day, 2 doxorubicin 1 day, 3 p6 4 day, 4 doxorubicin 4 day, 5 p6 7 day, 6 doxorubicin 7 day, 7 control DNA [7.6 ± 0.2], 8 DIG-Molecular Weight Marker [0.8–21.2]. d Representative pictures of Q-FISH for passage-dependent and premature senescence induced by doxorubicin. A passage-dependent telomere length shortening was observed but no changes in the mean telomere length during dox-induced SIPS were recorded](https://figures.cochat.ai/paper-figures/db2ea70e3d7042778274010ecc7b4e15/a-comparison-of-replicative-senescence-and-doxorubicin-induced-premature-figure-8.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, premature senescence also is observed with chronic stressors in both proliferative and post-mitotic cells in association with chronic oxidative stress or mitochondrial dysfunction and the induction of DNA damage [5, 25, 35, 59].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · cited 1×
“Whole cell protein extracts were prepared according to Laemmli (1970).”
MethodA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“Increased number of senescent cells has been described in many species mainly in tissues which contain mitotically competent cells (Dimri et al. 1995; Jeyapalan et al. 2007).”
BackgroundMethodInflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“Another feature of cellular senescence is the senescence associated secretory phenotype—SASP, which is characterized by the secretion of proinflammatory cytokines, which together with the process of inflammaging (Franceschi et al. 2000) can be responsible for low grade inflammatory state.”
BackgroundClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“It has been shown that removal of senescent cells can protect against an aging phenotype and therefore lead to rejuvenating of the organism (Baker et al. 2011; Thannickal 2013 and references herein).”
BackgroundHowell, W. M., & Black, D. A. (1980) · Experientia · doi:10.1007/bf01953855 · Cited by 2,920 · cited 1×
“For DNA synthesis assay, bromodeoxyuridine (BrdU, Sigma-Aldrich) was added to the medium (10 lM) for 24 h. Transcriptional rDNA activity was assessed as the size of AgNOR silver deposits as described elsewhere (Howell and Black 1980).”
MethodGewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
(2001) · Wiley eBooks · doi:10.1002/047001590x · Cited by 1,111
Vascular Calcification: Pathobiology of a Multifaceted Disease
Demer, L. L., & Tintut, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.743161 · Cited by 1,065 · cited 1×
“The calcification process of VSMCs shares many similarities with that of bone formation (Demer and Tintut 2008).”
BackgroundEndothelial Cell Senescence in Human Atherosclerosis: Role of Telomere in Endothelial Dysfunction
Minamino, T., Miyauchi, H., Yoshida, T., Ishida, Y., Yoshida, H., & Komuro, I. (2002) · Circulation · doi:10.1161/01.cir.0000013836.85741.17 · Cited by 1,061 · cited 5×
“There are also some cellular features characteristic only for senescent vascular cells (cell-type exclusive senescent phenotype—CESP), namely, an increased level of angiotensin II receptor and transdifferentiation of VSMCs to osteoblasts associated with the calcification process (Nakano-Kurimoto et al. 2009) or decrea…”
BackgroundInfluentialSenescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks
Sedelnikova, O. A., Horikawa, I., Zimonjic, D. B., Popescu, N. C., Bonner, W. M., & Barrett, J. C. (2004) · Nature Cell Biology · doi:10.1038/ncb1095 · Cited by 790
Toussaint, O., Medrano, E. E., & von Zglinicki, T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00180-7 · Cited by 713
DNA damage response and cellular senescence in tissues of aging mice
Wang, C., Jurk, D., Maddick, M., Nelson, G., Martin‐Ruiz, C., & Von Zglinicki, T. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00481.x · Cited by 696 · cited 2×
“We aimed to establish the signature of RS and SIPS of VSMCs, induced by a common anticancer drug, doxorubicin, and to discover the so far undisclosed features of senescent cells that are potentially harmful to the organism.”
BackgroundShanahan, C. M., Cary, N. R. B., Salisbury, J. R., Proudfoot, D., Weissberg, P. L., & Edmonds, M. E. (1999) · Circulation · doi:10.1161/01.cir.100.21.2168 · Cited by 642
Matthews, C., Gorenne, I., Scott, S., Figg, N., Kirkpatrick, P., Ritchie, A., Goddard, M., & Bennett, M. (2006) · Circulation Research · doi:10.1161/01.res.0000233315.38086.bc · Cited by 615 · cited 4×
“We fully support the opinion which has been proposed by Bennett’s group (Matthews et al. 2006) that prevention of cellular senescence may be a novel therapeutic target in atherosclerosis.”
BackgroundInfluentialAccumulation of senescent cells in Mitotic tissue of aging primates
Jeyapalan, J. C., Ferreira, M., Sedivy, J. M., & Herbig, U. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.008 · Cited by 571
DNA damage, cellular senescence and organismal ageing: causal or correlative?
Chen, J.-H., Hales, C. N., & Ozanne, S. E. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm681 · Cited by 476 · cited 2×
“It is believed that accumulation of senescent cells in tissues and organs causes multiple dysfunctions and can be the reason of age-related diseases (Chen et al. 2007).”
BackgroundImpact of aging on DNA methylation
Richardson, B. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00010-2 · Cited by 422 · cited 1×
“The age-related hypermethylation of the promoter regions of specific genes involved in cell cycle regulation, DNA repair, apoptosis, metabolism, cell signaling, plays a role in the age-related diseases (Richardson 2003).”
BackgroundVascular calcification in chronic kidney disease
Goodman, W. G., London, G., Amann, K., Block, G. A., Giachelli, C., Hruska, K. A., Ketteler, M., Levin, A., Massy, Z., McCarron, D. A., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.12.005 · Cited by 417
Cellular senescence, cancer and aging: the telomere connection
Campisi, J., Kim, S.-H., Lim, C.-S., & Rubio, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00160-7 · Cited by 400 · cited 1×
“This signaling pathway can be induced by DNA double strand breaks in telomeric regions during SIPS or telomere shortening during RS (Campisi et al. 2001).”
BackgroundThe role of epigenetics in aging and age-related diseases
Calvanese, V., Lara, E., Kahn, A., & Fraga, M. F. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.03.004 · Cited by 329 · cited 1×
“Another feature of senescence concerns the epigenome (Calvanese et al. 2009).”
Backgroundβ-Glycerophosphate Accelerates Calcification in Cultured Bovine Vascular Smooth Muscle Cells
Shioi, A., Nishizawa, Y., Jono, S., Koyama, H., Hosoi, M., & Morii, H. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.2003 · Cited by 290 · cited 2×
“These two factors added together to the culture medium can induce diffuse calcification in a manner analogous to in vitro mineralization of osteoblasts (Shioi et al. 1995).”
BackgroundMethodInfluentialThe p16INK4a-RB pathway : molecular link between cellular senescence and tumor suppression
Ohtani, N., Yamakoshi, K., Takahashi, A., & Hara, E. (2004) · The Journal of Medical Investigation · doi:10.2152/jmi.51.146 · Cited by 276 · cited 2×
“Some features of cellular senescence are universal for many types of cells and include: altered cell morphology, increased activity of senescence associated-b-galactosidase (SA-b-gal), accumulation of DNA damage foci and increased level of cyclindependent kinase inhibitors belonging to tumor suppressor pathways, namel…”
BackgroundAdriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
Elmore, L. W., Rehder, C. W., Di, X., McChesney, P. A., Jackson-Cook, C. K., Gewirtz, D. A., & Holt, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205477200 · Cited by 271 · cited 1×
“It was postulated previously that the mechanism of doxorubicin-induced SIPS depends on both functional p53 and telomere dysfunction rather than shortening, but such dysfunction can disrupt the telomere loop structure (Elmore et al. 2002).”
BackgroundImpact of cellular senescence signature on ageing research
Sikora, E., Arendt, T., Bennett, M., & Narita, M. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.10.002 · Cited by 264 · cited 3×
“It has been demonstrated that cellular senescence can be the result of a prolonged arrest of cells in mitosis which in consequence may cause disorganization of telomere binding factors 2 (TRF2) and the telomere structure (Hayashi et al. 2012.).”
BackgroundSelf-citationNakano-Kurimoto, R., Ikeda, K., Uraoka, M., Nakagawa, Y., Yutaka, K., Koide, M., Takahashi, T., Matoba, S., Yamada, H., Okigaki, M., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00455.2009 · Cited by 232 · cited 2×
“There are also some cellular features characteristic only for senescent vascular cells (cell-type exclusive senescent phenotype—CESP), namely, an increased level of angiotensin II receptor and transdifferentiation of VSMCs to osteoblasts associated with the calcification process (Nakano-Kurimoto et al. 2009) or decrea…”
BackgroundMaejima, Y., Adachi, S., Ito, H., Hirao, K., & Isobe, M. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00358.x · Cited by 224 · cited 2×
“There are some data showing that doxorubicin can induce premature senescence in cardiomyocytes (Maejima et al. 2008) and cardiac progenitor cells (Piegari et al. 2013), therefore we suggest that a similar side effect can be observed in VSMCs.”
BackgroundVascular smooth muscle cell senescence in atherosclerosis
GORENNE, I., KAVURMA, M., SCOTT, S., & BENNETT, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.004 · Cited by 196 · cited 1×
“…e-mail: g.mosieniak@nencki.gov.pl E. Sikora e-mail: e.sikora@nencki.gov.pl M. Wnuk A. Myszka Department of Genetics, University of Rzeszow, Rzeszow, Poland e-mail: mawnuk@gmail.com A. Myszka e-mail: amyszka@o2.pl Keywords Senescence VSMCs Doxorubicin Aging Cardiovascular diseases Calcification”
BackgroundAging, Atherosclerosis, and IGF-1
Higashi, Y., Sukhanov, S., Anwar, A., Shai, S.-Y., & Delafontaine, P. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls102 · Cited by 193 · cited 1×
“…e-mail: g.mosieniak@nencki.gov.pl E. Sikora e-mail: e.sikora@nencki.gov.pl M. Wnuk A. Myszka Department of Genetics, University of Rzeszow, Rzeszow, Poland e-mail: mawnuk@gmail.com A. Myszka e-mail: amyszka@o2.pl Keywords Senescence VSMCs Doxorubicin Aging Cardiovascular diseases Calcification”
BackgroundBennett, M. R., Macdonald, K., Chan, S.-W., Boyle, J. J., & Weissberg, P. L. (1998) · Circulation Research · doi:10.1161/01.res.82.6.704 · Cited by 191 · cited 1×
“It has been shown that VSMCs derived from human atherosclerotic plaques senesce faster than cells from normal vessels (Bennett et al. 1998).”
BackgroundMartinet, W., Knaapen, M. W. M., De Meyer, G. R. Y., Herman, A. G., & Kockx, M. M. (2001) · Circulation Research · doi:10.1161/hh0701.088684 · Cited by 171
Aging, cancer and nutrition: the DNA methylation connection
Liu, L., Wylie, R. C., Andrews, L. G., & Tollefsbol, T. O. (2003) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2003.08.001 · Cited by 167
A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest
Hayashi, M. T., Cesare, A. J., Fitzpatrick, J. A. J., Lazzerini-Denchi, E., & Karlseder, J. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2245 · Cited by 166
Doxorubicin induces senescence and impairs function of human cardiac progenitor cells
Piegari, E., Angelis, A., Cappetta, D., Russo, R., Esposito, G., Costantino, S., Graiani, G., Frati, C., Prezioso, L., Berrino, L., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0334-4 · Cited by 163 · cited 4×
“2008) and cardiac progenitor cells (Piegari et al. 2013), therefore we suggest that a similar side effect can be observed in VSMCs.”
BackgroundInfluentialSpallarossa, P., Altieri, P., Aloi, C., Garibaldi, S., Barisione, C., Ghigliotti, G., Fugazza, G., Barsotti, A., & Brunelli, C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00068.2009 · Cited by 160
Specific Age-Associated DNA Methylation Changes in Human Dermal Fibroblasts
Koch, C. M., Suschek, C. V., Lin, Q., Bork, S., Goergens, M., Joussen, S., Pallua, N., Ho, A. D., Zenke, M., & Wagner, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016679 · Cited by 134
Oxygen free radicals in cell senescence: Are they signal transducers?
Passos, J. F., & Von Zglinicki, T. (2006) · Free Radical Research · doi:10.1080/10715760600917151 · Cited by 122 · cited 1×
“We consider that detailed characterization of the two types of cellular senescence can be useful in in vitro studies of potential anti-aging factors.”
BackgroundDNA Methyltransferase Inhibition Induces the Transcription of the Tumor Suppressor p21
Milutinovic, S., Knox, J. D., & Szyf, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6353 · Cited by 111 · cited 1×
“An inverse relationship between the expression level of DNMT1 and p21 in mammalian cell cultures was reported (Milutinovic et al. 2000).”
BackgroundGlobal DNA methylation in old subjects is correlated with frailty
Bellizzi, D., D’Aquila, P., Montesanto, A., Corsonello, A., Mari, V., Mazzei, B., Lattanzio, F., & Passarino, G. (2011) · AGE · doi:10.1007/s11357-011-9216-6 · Cited by 111 · cited 2×
“molecular changes connected with aging (Bellizzi et al. 2012; Koch et al. 2011).”
BackgroundDNA damage, p53, apoptosis and vascular disease
Mercer, J. R., Mahmoudi, M., & Bennett, M. R. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.02.011 · Cited by 108 · cited 3×
“…in Biology and Medicine, Institute of Fundamental Technological Research, Polish Academy of Sciences, Pawińskiego 5B, Warsaw, Poland damage is augmented in cells isolated from atherosclerotic plaques as well as in the circulating cells of patients with atherosclerosis (Mercer et al. 2007).”
BackgroundInfluentialMechanistic links between aging and lung fibrosis
Thannickal, V. J. (2013) · Biogerontology · doi:10.1007/s10522-013-9451-6 · Cited by 107 · cited 1×
“It has been shown that removal of senescent cells can protect against an aging phenotype and therefore lead to rejuvenating of the organism (Baker et al. 2011; Thannickal 2013 and references herein).”
BackgroundAging, metabolic syndrome and the heart.
Veronica, G., & Esther, R.-R. M. (2012) · Europe PMC (PubMed Central) · Cited by 106
Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
Sun, J., Sun, G., Meng, X., Wang, H., Luo, Y., Qin, M., Ma, B., Wang, M., Cai, D., Guo, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064526 · Cited by 106
The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo
Lechel, A., Satyanarayana, A., Ju, Z., Plentz, R. R., Schaetzlein, S., Rudolph, C., Wilkens, L., Wiemann, S. U., Saretzki, G., Malek, N. P., et al. (2005) · EMBO reports · doi:10.1038/sj.embor.7400352 · Cited by 91
Telomere-driven replicative senescence is a stress response
von Zglinicki, T., Petrie, J., & Kirkwood, T. B. L. (2003) · Nature Biotechnology · doi:10.1038/nbt0303-229b · Cited by 76 · cited 1×
“The first one results from telomere shortening and/or loss of telomere function (von Zglinicki et al. 2003) and affects almost all proliferating somatic cell types in the organism (Sikora et al. 2011).”
BackgroundKorwek, Z., Sewastianik, T., Bielak-Żmijewska, A., Mosieniak, G., Alster, O., Moreno-Villaneuva, M., Bürkle, A., & Sikora, E. (2012) · DNA repair · doi:10.1016/j.dnarep.2012.08.006 · Cited by 60 · cited 3×
“We did not record any changes in the mean telomere length during dox-induced SIPS.”
BackgroundMethodSelf-citationKumari, A., Srinivasan, R., Vasishta, R. K., & Wig, J. D. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0333-8 · Cited by 55 · cited 2×
“Methylation regulates also the expression of the human telomerase reverse transcriptase gene (hTERT) (Kumari et al. 2009).”
BackgroundMethodToussaint, O., Dumont, P., Dierick, J., Pascal, T. G., Frippiat, C. C., Debacq‐Chainiaux, F., de Magalhães, J. P., Eliaers, F., & Remacle, J. (2000) · Biogerontology · doi:10.1023/a:1010035712199 · Cited by 40 · cited 3×
“Telomere length Although telomere erosion is considered to be the reason of cell division limit, it has been also observed in SIPS (Toussaint et al. 2000b).”
BackgroundInfluentialHodjat, M., Haller, H. G., Dumler, I., & Kiyan, Y. (2012) · Journal of Vascular Research · doi:10.1159/000343000 · Cited by 38 · cited 1×
“…one report concerning doxorubicin-induced senescence of VSMCs of the human umbilical artery, however, the experimental conditions were different than in our study—higher concentrations of doxorubicin, 0.25–1 lM were used, and all analyses were performed after 3 h of treatment (Hodjat et al. 2012).”
MethodInfluentialTelomere Length Analysis by Quantitative Fluorescent in Situ Hybridization (Q-FISH)
Ourliac-Garnier, I., & Londoño-Vallejo, A. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6892-3_3 · Cited by 32
Chatterjee, N., Kiran, S., Ram, B. M., Islam, N. S., Ramasarma, T., & Ramakrishna, G. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.04.005 · Cited by 16 · cited 1×
“Our result proved that accumulation of cells with a 4N DNA content can be used as a marker of premature senescence (Chatterjee et al. 2011).”
BackgroundRattan, S. I. S. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0002567.pub3 · Cited by 14 · cited 2×
“Cellular senescence is characterized by a series of morphological and physiological changes (Rattan 2012) including irreversible block of proliferation.”
BackgroundHan, W., Chuang, K., Chang, Y., Olivo, M., Velan, S. S., Bhakoo, K. K., Townsend, D. W., & Radda, G. K. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000074 · Cited by 13
Cited by
Senescent Cells in Cancer Therapy: Friends or Foes?
Wang, B., Kohli, J., & Demaria, M. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.05.004 · Cited by 508
“Vascular smooth muscle cells (i) Elevated SA-β-galactosidase activities (ii) Morphology (enlarged) (iii) G1 cell cycle arrest (iv) p53/p21 upregulation (v) p16 upregulation (vi) SASP induction (vii) Increased DDR 100 nM for 24 h [135]”
BackgroundSirtuins, a promising target in slowing down the ageing process
Grabowska, W., Sikora, E., & Bielak-Zmijewska, A. (2017) · Biogerontology · doi:10.1007/s10522-017-9685-9 · Cited by 470
Self-citationToxicity of Doxorubicin (Dox) to different experimental organ systems
Pugazhendhi, A., Edison, T. N. J. I., Velmurugan, B. K., Jacob, J. A., & Karuppusamy, I. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.023 · Cited by 452
Cappetta, D., De Angelis, A., Sapio, L., Prezioso, L., Illiano, M., Quaini, F., Rossi, F., Berrino, L., Naviglio, S., & Urbanek, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1521020 · Cited by 350
“SMCs exposed to DOX underwent cellular senescence and cell cycle arrest and experienced the common characteristics of senescent cells, such as DNA damage, generation of ROS, and SA-β-gal activity [78].”
BackgroundCellular senescence in brain aging
Sikora, E., Bielak-Zmijewska, A., Dudkowska, M., Krzystyniak, A., Mosieniak, G., Wesierska, M., & Wlodarczyk, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646924 · Cited by 304
Self-citation
Metadata
- Authors
- Bielak-Zmijewska, A., Wnuk, M., Przybylska, D., Grabowska, W., Lewinska, A., Alster, O., Korwek, Z., Cmoch, A., Myszka, A., Pikula, S., Mosieniak, G., & Sikora, E.
- Affiliations
- University of Rzeszów (PL)
- Instytut Biologii Doświadczalnej im. Marcelego Nenckiego (PL)
- Venue
- Biogerontology
- Published
- 2013-11-16
- Volume
- 15
- Issue
- 1
- Pages
- 47-64
- ISSN
- 1389-5729 (ISSN-L)
- 1573-6768
- PMC
- PMC3905196
- OpenAlex
- W2077475477
- Cited by
- 139
- References
- 52
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 9 · 2023: 10 · 2022: 17 · 2021: 15 · 2020: 16 · 2019: 13 · 2018: 11 · 2017: 14 · 2016: 7 · 2015: 4 · 2014: 2
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Biogerontology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Instytut Biologii Doswiadczalnej im. M. Nenckiego PAN
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- replicative senescence, stress-induced premature senescence, vascular smooth muscle cells, doxorubicin, G2/M cell cycle arrest, G1 cell cycle arrest, alkaline phosphatase activity, atherosclerosis, human aorta
- MeSH terms
- DNA (Cytosine-5-)-Methyltransferase 1, Alkaline Phosphatase, Aorta, beta-Galactosidase, Cell Cycle, Cell Line, Cells, Cultured, DNA (Cytosine-5-)-Methyltransferases, Dose-Response Relationship, Drug, Doxorubicin, Humans, Male, Muscle, Smooth, Vascular, Superoxides, Cellular Senescence, Aging, Premature, Cell Proliferation, Young Adult, Telomere Homeostasis, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.